CVRx Logo_R_RGB_black.png
CVRx Added to Russell 2000® and 3000® Indexes
17 sept. 2021 08h00 HE | CVRx, Inc.
MINNEAPOLIS, Sept. 17, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and...
logo 02.jpg
Heart Failure POC and LOC Devices Market Worth USD 175.35 Million by 2027 at 16.2% - Report by Market Research Future (MRFR)
19 août 2021 12h00 HE | Market Research Future
New York, US, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Heart Failure POC & LOC Devices Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Heart...
CVRx Logo_R_RGB_black.png
CVRx Reports Second Quarter 2021 Financial and Operating Results
04 août 2021 16h05 HE | CVRx, Inc.
MINNEAPOLIS, Aug. 04, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and...
CVRx Logo_R_RGB_black.png
CVRx to Present at the Canaccord Genuity 41st Annual Growth Conference
29 juil. 2021 16h05 HE | CVRx, Inc.
MINNEAPOLIS, July 29, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally...
Gencaro Atrial Fibrillation Phase 2B Results Selected for Publication in Circulation: Arrhythmia and Electrophysiology
28 juil. 2021 08h00 HE | ARCA biopharma, Inc.
Analysis in full patient cohort shows Gencaro effect compared to standard of careIn the GENETIC-AF entire cohort of heart failure patients treated with Gencaro, compared to patients treated with...
CVRx Logo_R_RGB_black.png
CVRx to Report Second Quarter 2021 Financial and Operating Results and Host Conference Call
21 juil. 2021 17h28 HE | CVRx, Inc.
MINNEAPOLIS, July 21, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative and minimally...
CVRx Welcomes Veteran Life Science Industry Leader Martha Shadan to its Board of Directors
12 juil. 2021 08h00 HE | CVRx, Inc.
MINNEAPOLIS, July 12, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative and minimally...
CVRx Logo_R_RGB_black.png
CVRx, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
02 juil. 2021 16h05 HE | CVRx, Inc.
MINNEAPOLIS, July 02, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally...
CVRx Logo_R_RGB_black.png
CVRx, Inc. Announces Upsized Pricing of Initial Public Offering
29 juin 2021 20h17 HE | CVRx, Inc.
MINNEAPOLIS, June 29, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally...
CVRx Logo_R_RGB_black.png
CVRx® Announces First Clinical Procedure with a New Ultrasound-Guided Implant Approach, the Latest Advancement in Barostim™ for the Treatment of Heart Failure Symptoms
10 juin 2021 11h19 HE | CVRx, Inc.
MINNEAPOLIS, June 10, 2021 (GLOBE NEWSWIRE) -- CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced the completion of the...